Dynavax Technologies Corp Stock
Dynavax Technologies Corp shows a slight decrease today, losing -€0.090 (-0.950%) compared to yesterday.
Our community is currently high on Dynavax Technologies Corp with 3 Buy predictions and 1 Sell predictions.
Based on the current price of 9.44 € the target price of 29 € shows a potential of 207.07% for Dynavax Technologies Corp which would more than double the current price.
Pros and Cons of Dynavax Technologies Corp in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
M***** P*******
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Comments
Dynavax Technologies (NASDAQ:DVAX) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for DVAX provided by MarketBeat
Dynavax Technologies Co. (NASDAQ: DVAX) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $12.00 to $10.00. They now have a "sell" rating on the stock.
Show more
Ratings data for DVAX provided by MarketBeat
Dynavax Technologies Co. (NASDAQ: DVAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $31.00 price target on the stock.
Show more
Ratings data for DVAX provided by MarketBeat
News
Why Dynavax Stock Soared Today
Shares of Dynavax Technologies (NASDAQ: DVAX) popped on Wednesday after the vaccine maker struck a deal to be acquired by Sanofi (NASDAQ: SNY).
As of 3:00 p.m. EST, Dynavax's stock price was up
Dynavax (DVAX) Q2 Revenue Jumps 29%
Dynavax Technologies (NASDAQ:DVAX), a biotechnology company focused on vaccines, released its results for the second quarter of 2025 on August 7, 2025. The company posted GAAP revenue of $95.4